Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? by Barwell, J et al.
Is telomere length in peripheral blood lymphocytes correlated
with cancer susceptibility or radiosensitivity?
J Barwell
1, L Pangon
1, A Georgiou
1, Z Docherty
1, I Kesterton
1, J Ball
1, R Camplejohn
2, J Berg
3, A Aviv
4,
J Gardner
4, BS Kato
5, N Carter
1, D Paximadas
5, TD Spector
5 and S Hodgson*,6
1Medical and Molecular Genetics Department, Guy’s Hospital, London SE1 9RT, UK;
2King’s College London School of Medicine, Department of
Oncology, Rayne Institute, London SE1 7EH, UK;
3Clinical Genetics Department, Ninewells Hospital Medical School, Dundee DD1 9SY, UK;
4Hypertension Research Center, University of Medicine and Dentistry of New Jersey, 185 South Orange Ave, Newark, NJ 07103-2714, USA;
5King’s
College London, Twin Research & Genetic Epidemiology Unit, St Thomas’ Hospital Campus, Lambeth Palace Road, London SE1 7EH, UK;
6Clinical
Genetics, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK
Mean terminal restriction fragment (TRF) lengths in white blood cells (WBCs) have been previously found to be associated with
breast cancer. To assess whether this marker could be used as a test for breast cancer susceptibility in women, TRF length was
measured in 72 treated female breast cancer patients and 1696 unaffected female controls between the ages of 45 and 77 from the
Twin Research Unit at St Thomas’ Hospital, as well as 140 newly diagnosed breast cancer cases and 108 mammographically screened
unaffected controls from Guy’s Hospital. Mean TRF was also tested for correlation with chromosome radiosensitivity and apoptotic
response in the Guy’s Hospital patients. After adjusting for age, smoking and body mass index, there was no significant difference in
TRF lengths between the treated breast cancer patients and unaffected controls (P¼0.71). A positive correlation between age-
adjusted apoptotic response and mean TRF in newly diagnosed untreated breast cancer patients (P¼0.008) was identified but no
significant difference in TRF lengths between breast cancer patients and unaffected controls was detected (P¼0.53). This suggests
that TRF lengths in WBC, is not a marker of breast cancer susceptibility and does not vary significantly between affected women
before and after treatment.
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Telomeres, a series of TTAGGG repeat sequences, are located at the
end of chromosomes and prevent these being recognised as
double-strand breaks (Blackburn, 2001). We have previously
shown that telomere length in white blood cells (WBC) is inversely
correlated with age, smoking and body mass index (BMI) (Benetos
et al, 2001; Valdes et al, 2005). A link between mean terminal
restriction fragment (TRF) lengths in WBC and cancer suscepti-
bility is, however, less certain (Wu et al, 2003). DNA damage
response proteins are thought to be involved in telomere
maintenance (Slijepcevic, 2004) and this suggests that telomere
shortening could be related to breast cancer susceptibility. It is
possible that short telomeres reflect increased cell turnover or the
loss of key/critical genes in the telomeric region, which could lead
to a failure of apoptosis or the development of chromosomal
instability (Kim et al, 2002; Preto et al, 2004). Meeker and Argani
(2004) demonstrated that somatic telomere length is significantly
shorter in premalignant ductal carcinoma in situ than in normal
breast tissue.
An association of short telomeres with hypersensitivity to
ionising irradiation has been reported previously (Goytisolo et al,
2000; Bouffler et al, 2001) and it has been suggested that it could
be important in determining tissue sensitivity to radiotherapy
(Wu et al, 2003). Telomere length in radiosensitive murine
lymphoma cells L5178Y-S has been shown to be seven-fold shorter
than in radioresistant cells and a significant inverse correlation
between telomere length and chromosomal radiosensitivity has
previously been observed in lymphocytes from 24 breast cancer
patients and 5 normal individuals (McIlrath et al, 2001).
This link between radiosensitivity and telomere shortening in
peripheral blood lymphocytes could be due to a defect in
homologous recombination repair of both double-strand breaks
and telomere uncapping (Wong et al, 2000).
To determine whether mean TRF is associated with breast
cancer susceptibility, we assessed mean TRF in WBCs from 72
treated (female) breast cancer patients and 1696 unaffected female
controls between the ages of 45 and 77 from the Twin Research
Unit at St Thomas’ Hospital. To exclude the possible effect of
chemotherapy/radiotherapy or surgery on these assays mean TRF
was also measured in 140 newly diagnosed untreated breast cancer
patients and 108 age, sex and ethnically matched controls.
We also present the correlation between TRF and two in vitro
markers of radiosensitivity (chromosome radiosensitivity and
induced apoptotic response to irradiation) in peripheral blood
lymphocytes from these newly diagnosed breast cancer patients
and unaffected controls, and discuss their significance.
Received 4 July 2007; revised 15 October 2007; accepted 15 October
2007; published online 13 November 2007
*Correspondence: Professor S Hodgson; E-mail: shodgson@sgul.ac.uk
British Journal of Cancer (2007) 97, 1696–1700
& 2007 Cancer Research UK All rights reserved 0007– 0920/07 $30.00
www.bjcancer.com
G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
sMATERIALS AND METHODS
Recruitment of breast cancer treated individuals and
unaffected controls
Data were available on 7674 female twins who reported if they had
ever been diagnosed with breast cancer. These data came from four
sources, namely twin interviews, questionnaire 2 (1999), ques-
tionnaire 7 (2002) and baseline health questionnaire from Twins
UK (2004–present). Of the 7674 twins, 2597 had measurements on
TRF length and therefore the rest of the report will deal with these
2597 subjects (72 had been treated previously for breast cancer,
2525 had never had breast cancer).
Recruitment of newly diagnosed breast cancer individuals
and unaffected controls
Terminal restriction fragment lengths were measured in DNA
extracted from the WBCs of 140 newly diagnosed untreated female
breast cancer patients (mean age¼59, range¼27–85) with no
previous history of cancer and before treatment with radiotherapy
or chemotherapy and 108 age- and ethnicity-matched female
controls with a normal mammogram in the last 6 months. The
unaffected controls (mean age¼55, range¼26–83) were recruited
as close as possible in time to the cases, from breast outpatient and
mammographic screening clinics.
Mean TRF measurement
The mean TRF lengths were then age-adjusted and correlated with
two in vitro markers of radiosensitivity, apoptotic response to
irradiation and chromosome breakage using the G2 assay. Mean
TRF length, radiosensitivity, apoptotic response to irradiation and
chromosome breakage were available in 123 newly diagnosed
breast cancer patients and 108 unaffected controls. The coefficient
of variation of the TRF length measurement assay in this study
was 1.4%.
The methods and results of testing for chromosome radio-
sensitivity and apoptotic response to irradiation in these newly
diagnosed breast cancer patients and controls are described in
more detail in Docherty et al (2007). They are described in brief as
follows:
G2 radiosensitivity assay
This was carried out according to Howell and Taylor (1992). Six
whole blood cultures from heparinised blood samples were
incubated for 65h at 371C. The cells were irradiated using a
caesium-137 source at 0.5/1Gy, or mock treated. The cells were
re-incubated for 30min or 3h. Colcemid was added and harvested
1h later using KCl and methanol/acetic acid fixative. The slides
were stained with leishmans and 50 metaphases were scored blind
for chromatid breaks.
Apoptotic assay
Peripheral blood lymyphocytes were separated by centrifugation
on histopaque and cultured for 70h. The cells were irradiated with
4Gy using a caesium-137 source or mock treated. The cells were
re-cultured for a further 24h and then fixed in 70% ethanol. The
ethanol was removed and the DNA was denatured in HCl and
stained for DNA content with propidium iodide. DNA content was
assessed by flow cytometry.
Statistical analysis
Standard multiple regression techniques were used to investigate
associations between TRF length and age- and age-adjusted TRF
length with apoptotic response and disease status. Stata 9.0
software was used. The regression cluster option in Stata was used
to account for correlation within twin pairs. Apoptotic response to
irradiation and age-adjusted mean TRFs were correlated using
linear regression analysis. With 108 breast cancer cases and 140
controls, a difference of 200bp would be detected with a power of
62% at a 0.05 level of significance.
Out of the 1768 individuals, 1713 had two TRF measure-
ments taken. A paired t-test comparing intra-individual TRF
measurements using the Southern blot technique from the
Twins Unit treated breast cancer patients and unaffected
controls was carried out. On average there was an extremely
small (0.009kb) but significant difference between the sample
measurements from the same individuals (P¼0.0322). This
is very unlikely to be the cause of a type I error in this study
and a true significant difference between cases and controls
missed.
RESULTS
TRF in breast cancer patients post-treatment and
unaffected controls
Complete data on TRF length were available for 2525 controls and
72 breast cancer treated patients. However, the mean age of the
cases was significantly greater than that of controls (56.3 vs 47.9,
Po0.001). To obtain a better age match for the cases and controls,
we considered only controls aged between 45 and 77 years. This
rendered a sample of 1768 (1696 controls and 72 cases) subjects
with no significant difference between the mean ages in each group
(56.27 vs 55.09, P¼0.22).
The relationship between TRF length and age in all subjects
is shown in Figure 1. Overall TRF length decreased with age in
both groups with a correlation in cases of  0.27 and controls
 0.22. After adjusting for age, there was no significant difference
in mean TRF lengths of subjects who had had breast cancer and
those who had never had breast cancer (6.859kb vs 6.858,
P¼0.988).
TRF in newly diagnosed breast cancer patients and
unaffected controls
Terminal restriction fragment length was successfully measured in
248 subjects, 140 newly diagnosed, untreated female breast cancer
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Figure 1 Relationship between mean terminal restriction fragment
(TRF) length in white blood cell (WBC) and age in 72 women post-breast
cancer treatment and 1696 healthy controls recruited from the Twins Unit
at St Thomas’ Hospital.
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subjects were female and cases were on average older than controls
(57.3 vs 54.0 years, P¼0.034).
The relationship between TRF length and age in these subjects is
shown in Figure 2. Overall TRF length decreased similarly with age
in both groups with a correlation in cases of  0.47 and controls
 0.49. A comparison of average TRF lengths of cases and controls
adjusting for age revealed that the age-adjusted TRF length of
breast cancer cases and controls did not differ (6.65kb for cases vs
6.60 for controls; P¼0.529).
Correlation between mean TRF length and chromosome
radiosensitivity and apoptotic response to irradiation
There was no significant correlation between radiosensitivity and
TRF length in 123 newly diagnosed, untreated breast cancer
patients and 102 unaffected controls.
There was a significant positive correlation between age-
adjusted apoptotic response to irradiation and mean telomere
length in 123 newly diagnosed breast cancer patients (r¼0.236,
P¼0.008) (Figure 3). No significant correlation was present
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Figure 2 Relationship between mean terminal restriction fragment
(TRF) length in white blood cell (WBC) and age in 140 newly diagnosed
and untreated breast cancer cases and 108 unaffected controls with a
normal mammogram in the previous 6 months.
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Figure 3 Correlation of percentage peripheral blood lymphocyte apoptotic response to irradiation to mean age-adjusted white blood cell (WBC)
terminal restriction fragment (TRF) length in newly diagnosed breast cancer patients (N¼123, r¼0.236, P¼0.008).
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Figure 4 Correlation of percentage peripheral blood lymphocyte apoptotic response to irradiation to mean age-adjusted white blood cell (WBC)
terminal restriction fragment (TRF) length in unaffected controls with a normal mammogram in the previous 6 months (N¼102, r¼0.148, P¼0.137).
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P¼0.137) (Figure 4).
DISCUSSION
This is the largest study of mean TRF measurement in WBC from
breast cancer patients and unaffected controls. It has been
demonstrated that loss of telomeres increases chromosomal
instability resulting in chromosomal rearrangements associated
with carcinogenesis (Murnane, 2006) and tumour cell progression
(Lo et al, 2002). As a result, telomere length has been used as a
marker of disease progression in solid tumours (Bisoffi et al, 2006;
Fordyce et al, 2006). Mean TRF length has previously been shown
to decrease with age. However, as previously demonstrated in
mouse cell lines, no statistical difference in age-adjusted mean TRF
was demonstrated between any of the breast cancer patient groups
and unaffected control groups. Therefore, we found no evidence
that a reduction or increase in TRF in WBCs is linked to breast
cancer susceptibility, as was previously suggested in a smaller
study (McIlrath et al, 2001).
When the results are controlled for BMI and smoking status,
there is no evidence that average TRF length differs between breast
cancer cases and controls (P¼0.707) (Table 1). No association
between chromosome radiosensitivity and BMI or smoking was
found in the newly diagnosed breast cancer patients and
age-matched controls (Docherty et al, 2007).
Why was no difference found between breast cancer cases
and controls, as previously suggested?
This is a much larger cohort of age-matched breast cancer patients
than previous studies. Pre- and post-treatment breast cancer
patients were analysed and compared with controls separately and
therefore it is unlikely that treatment itself is the reason why no
difference was found.
Our studies used peripheral blood lymphocytes rather than
somatic tumour tissue or established cell lines, which may have
different TRF measurements and radiosensitivity, respectively. The
newly diagnosed breast cancer patients were controlled with
patients who had had a normal mammogram reported after a
technical repeat mammogram in the previous 6 months. This may
give different results compared to other control groups.
We have previously shown that there was no significant
difference between apoptotic response to irradiation and chromo-
some radiosensitivity between newly diagnosed breast cancer cases
and controls (Camplejohn et al, 1995, 2003). However, in line with
these studies, we detected a decline in final induced apoptotic
response with age in both patients and unaffected controls
(Docherty et al, 2007). By combining our results, we have shown
a significant positive correlation between age-adjusted apoptotic
response to irradiation and mean telomere length in WBC from
newly diagnosed breast cancer patients (P¼0.008). This trend was
also observed in the unaffected controls. Loss of telomeric
sequences could theoretically alter the cell’s ability to undergo
apoptosis after irradiation, due to loss of key apoptotic or DNA
damage-sensing genes.
Our results demonstrated that the mean TRF and apoptotic
response to irradiation in WBC reduce with age, and that
age-adjusted mean TRF is correlated with apoptotic response to
irradiation. This could be due to shared genetic mechanisms for
TRF maintenance and apoptotic response to irradiation. However,
within the power constraints of our study, age-adjusted mean TRF
in WBCs is not a marker of breast cancer susceptibility.
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